AKTX Stock Analysis: Buy, Sell, or Hold?
AKTX - Akari Therapeutics plc ADR (0.01 USD)
$14.99
0.35 (2.43%)
▲
5d:
-5.9%
30d:
+150.17%
90d:
+5894.0%
WAIT
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When AKTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: AKTX is 26.2% above its trading range ($11.87). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: AKTX is 26.2% above its trading range ($11.87). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: AKTX is currently trading at $14.98, which is considered extended relative to its 30-day fair value range of $2.09 to $11.87.
Technical Outlook: Technically, AKTX is in a uptrend. Immediate support is located at $3.15, while resistance sits at $29.32.
Market Sentiment: AKTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $26.78 (+78.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AKTX is in a uptrend. Immediate support is located at $3.15, while resistance sits at $29.32.
Market Sentiment: AKTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $26.78 (+78.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.09 -
$11.87
Company Quality Score
53/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+26.2% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: Trading 78.7% below Wall St target ($26.78)
- WARNING: Recommendation downgraded due to 26.2% overvaluation
Trading Range Analysis
30-Day Trading Range
$2.09 -
$11.87
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.15
Resistance Level
$29.32
Current Trend
Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.40
Wall Street Target
$26.78
(+78.7%)
Share & Embed Analysis
Last updated: June 03, 2026 6:37 PM ET
Data refreshes hourly during market hours. Next update: 7:37 PM
Data refreshes hourly during market hours. Next update: 7:37 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AKTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 55 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 62 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$123 | 50 HOLD |
